Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes |
Behzad, Mansoori
(Immunology Research Center, Tabriz University of Medical Sciences)
Ali, Mohammadi (Immunology Research Center, Tabriz University of Medical Sciences) Solmaz, Shirjang (Immunology Research Center, Tabriz University of Medical Sciences) Elham, Baghbani (Immunology Research Center, Tabriz University of Medical Sciences) Behzad, Baradaran (Immunology Research Center, Tabriz University of Medical Sciences) |
1 | Shi X-B, Tepper CG, deVere White RW (2008). Cancerous miRNAs and their regulation. Cell Cycle, 7, 1529-38. DOI |
2 | Thun MJ, DeLancey JO, Center MM, et al (2010). The global burden of cancer: priorities for prevention. Carcinogenesis, 31, 100-10. DOI |
3 | Yao Y, Hu J, Shen Z, et al (2015). MiR 200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1. J Cellular Molecular Med, 19, 760-9. DOI |
4 | Yu F, Yao H, Zhu P, et al (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-23. DOI |
5 | Zenz T, Mohr J, Eldering E, et al (2009). miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood, 113, 3801-8. DOI |
6 | Zhang D-G, Zheng J-N, Pei D-S (2014). P53/microRNA- 34-induced metabolic regulation: new opportunities in anticancer therapy. Molecular Cancer, 13, 1-7. DOI |
7 | Bussing I, Slack FJ, Grosshans H (2008). let-7 microRNAs in development, stem cells and cancer. Trends Molecular Med, 14, 400-9. DOI |
8 | Chou J, Shahi P, Werb Z (2013). microRNA-mediated regulation of the tumor microenvironment. Cell Cycle, 12, 3262-71. DOI |
9 | Costa PM, Pedroso de Lima MC (2013). MicroRNAs as molecular targets for cancer therapy: on the modulation of microRNA expression. Pharmaceuticals, 6, 1195-220. DOI |
10 | Davis S, Lollo B, Freier S, et al (2006). Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res, 34, 2294-304. DOI |
11 | Fang Y, Gao W (2014). Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene, 33, 135-47. DOI |
12 | Hannafon BN, Sebastiani P, de las Morenas A, et al (2011). Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res, 13, 24. |
13 | Fridman JS, Lowe SW (2003). Control of apoptosis by p53. Oncogene, 22, 9030-40. DOI |
14 | Garzon R, Calin GA, Croce CM (2009). MicroRNAs in cancer. Annual Review Med, 60, 167-79. DOI |
15 | Giono LE, Manfredi JJ (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cellular Physiol, 209, 13-20. DOI |
16 | Iorio MV, Casalini P, Tagliabue E, et al (2008). MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer, 44, 2753-9. DOI |
17 | Kumar MS, Erkeland SJ, Pester RE, et al (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA, 105, 3903-8. DOI |
18 | Mansoori B, Mohammadi A, Shirjang S, et al (2014). Micro- RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cellular Molecular Biol, 61, 1-10. |
19 | Ong CC, Gierke S, Pitt C, et al (2015). Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents. Breast Cancer Res, 17, 59. DOI |
20 | Peltier HJ, Latham GJ (2008). Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA, 14, 844-52. DOI |
21 | Reis LO, Pereira TC, Lopes-Cendes I, et al (2010). MicroRNAs: a new paradigm on molecular urological oncology. Urol, 76, 521-7. DOI |